{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:26:50Z","timestamp":1793917610570,"version":"4.8.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-026-01169-4","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:02:32Z","timestamp":1778835752000},"page":"1133-1148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CD300ld on pathologically activated neutrophils promotes tumor immune suppression by binding phosphatidylserine on CD8+ T cells"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-7074","authenticated-orcid":false,"given":"Chaoxiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3963-3051","authenticated-orcid":false,"given":"Peixuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2933-0460","authenticated-orcid":false,"given":"Xinrui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4983-3275","authenticated-orcid":false,"given":"Chaogui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1821-2741","authenticated-orcid":false,"given":"Dong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adili","family":"Salai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-4848","authenticated-orcid":false,"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-7848","authenticated-orcid":false,"given":"Zhigang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-4678","authenticated-orcid":false,"given":"Dianfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0686-688X","authenticated-orcid":false,"given":"Moubin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-574X","authenticated-orcid":false,"given":"Jiayin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8223-705X","authenticated-orcid":false,"given":"Guohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9788-2087","authenticated-orcid":false,"given":"Shuo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-6094","authenticated-orcid":false,"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"1169_CR1","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1007\/s00262-023-03441-3","volume":"72","author":"Y Mao","year":"2023","unstructured":"Mao, Y. et al. The landscape of objective response rate of anti-PD-1\/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating. Cancer Immunol. Immunother. 72, 2483\u20132498 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"1169_CR2","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S1470-2045(20)30234-5","volume":"21","author":"M Ochoa de Olza","year":"2020","unstructured":"Ochoa de Olza, M., Navarro Rodrigo, B., Zimmermann, S. & Coukos, G. Turning up the heat on non-immunoreactive tumours: opportunities for clinical development. Lancet Oncol. 21, e419\u2013e430 (2020).","journal-title":"Lancet Oncol."},{"key":"1169_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu, B., Zhang, B., Li, B., Wu, H. & Jiang, M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct. Target. Ther. 9, 274 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1169_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41577-025-01161-6","volume":"25","author":"L Galluzzi","year":"2025","unstructured":"Galluzzi, L., Smith, K. N., Liston, A. & Garg, A. D. The diversity of CD8+ T cell dysfunction in cancer and viral infection. Nat. Rev. Immunol. 25, 662\u2013679 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"1169_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41568-024-00761-z","volume":"25","author":"D Hanahan","year":"2025","unstructured":"Hanahan, D., Michielin, O. & Pittet, M. J. Convergent inducers and effectors of T cell paralysis in the tumour microenvironment. Nat. Rev. Cancer 25, 41\u201358 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"1169_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02242-7","volume":"10","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y., Shen, G., Zhou, X. & Li, J. Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity. Signal Transduct. Target. Ther. 10, 178 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1169_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41573-025-01210-8","volume":"24","author":"JW Kwak","year":"2025","unstructured":"Kwak, J. W. & Houghton, A. M. Targeting neutrophils for cancer therapy. Nat. Rev. Drug Discov. 24, 666\u2013684 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1169_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6493","volume":"383","author":"MSF Ng","year":"2024","unstructured":"Ng, M. S. F. et al. Deterministic reprogramming of neutrophils within tumors. Science 383, eadf6493 (2024).","journal-title":"Science"},{"key":"1169_CR9","doi-asserted-by":"publisher","first-page":"e20201803","DOI":"10.1084\/jem.20201803","volume":"218","author":"F Veglia","year":"2021","unstructured":"Veglia, F. et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J. Exp. Med. 218, e20201803 (2021).","journal-title":"J. Exp. Med."},{"key":"1169_CR10","doi-asserted-by":"publisher","first-page":"e1494113","DOI":"10.1080\/2162402X.2018.1494113","volume":"7","author":"PF Wang","year":"2018","unstructured":"Wang, P. F. et al. Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: a meta-analysis of 40 studies. Oncoimmunology 7, e1494113 (2018).","journal-title":"Oncoimmunology"},{"key":"1169_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/11795549211035540","volume":"15","author":"T Li","year":"2021","unstructured":"Li, T. et al. Targeting MDSC for immune-checkpoint blockade in cancer immunotherapy: current progress and new prospects. Clin. Med. Insights Oncol. 15, 11795549211035540 (2021).","journal-title":"Clin. Med. Insights Oncol."},{"key":"1169_CR12","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.4049\/jimmunol.0902661","volume":"184","author":"S Nagaraj","year":"2010","unstructured":"Nagaraj, S., Schrum, A. G., Cho, H. I., Celis, E. & Gabrilovich, D. I. Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J. Immunol. 184, 3106\u20133116 (2010).","journal-title":"J. Immunol."},{"key":"1169_CR13","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.1074\/jbc.M111.279224","volume":"287","author":"E Comas-Casellas","year":"2012","unstructured":"Comas-Casellas, E. et al. Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors. J. Biol. Chem. 287, 9682\u20139693 (2012).","journal-title":"J. Biol. Chem."},{"key":"1169_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","volume":"621","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. CD300ld on neutrophils is required for tumour-driven immune suppression. Nature 621, 830\u2013839 (2023).","journal-title":"Nature"},{"key":"1169_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"1169_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/eji.201847951","volume":"49","author":"J Vitalle","year":"2019","unstructured":"Vitalle, J., Terren, I., Orrantia, A., Zenarruzabeitia, O. & Borrego, F. CD300 receptor family in viral infections. Eur. J. Immunol. 49, 364\u2013374 (2019).","journal-title":"Eur. J. Immunol."},{"key":"1169_CR17","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1182\/blood-2012-09-435057","volume":"121","author":"F Borrego","year":"2013","unstructured":"Borrego, F. The CD300 molecules: an emerging family of regulators of the immune system. Blood 121, 1951\u20131960 (2013).","journal-title":"Blood"},{"key":"1169_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","volume":"39","author":"PA Leventis","year":"2010","unstructured":"Leventis, P. A. & Grinstein, S. The distribution and function of phosphatidylserine in cellular membranes. Annu. Rev. Biophys. 39, 407\u2013427 (2010).","journal-title":"Annu. Rev. Biophys."},{"key":"1169_CR19","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1182\/blood-2006-03-011742","volume":"108","author":"K Fischer","year":"2006","unstructured":"Fischer, K. et al. Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. Blood 108, 4094\u20134101 (2006).","journal-title":"Blood"},{"key":"1169_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ncb1279","volume":"7","author":"JI Elliott","year":"2005","unstructured":"Elliott, J. I. et al. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat. Cell Biol. 7, 808\u2013816 (2005).","journal-title":"Nat. Cell Biol."},{"key":"1169_CR21","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/cdd.2014.86","volume":"21","author":"Y Murakami","year":"2014","unstructured":"Murakami, Y. et al. CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition. Cell Death Differ. 21, 1746\u20131757 (2014).","journal-title":"Cell Death Differ."},{"key":"1169_CR22","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.4049\/jimmunol.1101549","volume":"187","author":"SC Choi","year":"2011","unstructured":"Choi, S. C. et al. Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis. J. Immunol. 187, 3483\u20133487 (2011).","journal-title":"J. Immunol."},{"key":"1169_CR23","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1182\/blood-2011-08-372425","volume":"119","author":"VR Simhadri","year":"2012","unstructured":"Simhadri, V. R. et al. Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 119, 2799\u20132809 (2012).","journal-title":"Blood"},{"key":"1169_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-020-00214-z","volume":"25","author":"MB Naeini","year":"2020","unstructured":"Naeini, M. B., Bianconi, V., Pirro, M. & Sahebkar, A. The role of phosphatidylserine recognition receptors in multiple biological functions. Cell. Mol. Biol. Lett. 25, 23 (2020).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"1169_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1158\/2326-6066.CIR-13-0073","volume":"1","author":"Y Yin","year":"2013","unstructured":"Yin, Y., Huang, X., Lynn, K. D. & Thorpe, P. E. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol. Res. 1, 256\u2013268 (2013).","journal-title":"Cancer Immunol. Res."},{"key":"1169_CR26","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1158\/1078-0432.CCR-23-0203","volume":"29","author":"KI Ly","year":"2023","unstructured":"Ly, K. I. et al. Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients. Clin. Cancer Res. 29, 3017\u20133025 (2023).","journal-title":"Clin. Cancer Res."},{"key":"1169_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46542-y","volume":"15","author":"D Hsiehchen","year":"2024","unstructured":"Hsiehchen, D. et al. The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial. Nat. Commun. 15, 2178 (2024).","journal-title":"Nat. Commun."},{"key":"1169_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","volume":"36","author":"S Nagata","year":"2018","unstructured":"Nagata, S. Apoptosis and clearance of apoptotic cells. Annu. Rev. Immunol. 36, 489\u2013517 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"1169_CR29","doi-asserted-by":"publisher","first-page":"111582","DOI":"10.1016\/j.celrep.2022.111582","volume":"41","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy. Cell Rep. 41, 111582 (2022).","journal-title":"Cell Rep."},{"key":"1169_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","volume":"39","author":"A Chow","year":"2021","unstructured":"Chow, A. et al. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. Cancer Cell 39, 973\u2013988 (2021).","journal-title":"Cancer Cell"},{"key":"1169_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.755995","volume":"12","author":"A MacDonald","year":"2021","unstructured":"MacDonald, A. et al. Delivery of IL-2 to the T cell surface through phosphatidylserine permits robust expansion of CD8 T cells. Front. Immunol. 12, 755995 (2021).","journal-title":"Front. Immunol."},{"key":"1169_CR32","doi-asserted-by":"publisher","first-page":"e152864","DOI":"10.1172\/JCI152864","volume":"132","author":"O Pagliano","year":"2022","unstructured":"Pagliano, O. et al. Tim-3 mediates T cell trogocytosis to limit antitumor immunity. J. Clin. Invest. 132, e152864 (2022).","journal-title":"J. Clin. Invest."},{"key":"1169_CR33","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41423-020-00600-9","volume":"18","author":"N Wu","year":"2021","unstructured":"Wu, N., Song, H. & Veillette, A. Plasma membrane lipid scrambling causing phosphatidylserine exposure negatively regulates NK cell activation. Cell. Mol. Immunol. 18, 686\u2013697 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"1169_CR34","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nature25442","volume":"553","author":"G Pasqual","year":"2018","unstructured":"Pasqual, G. et al. Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling. Nature 553, 496\u2013500 (2018).","journal-title":"Nature"},{"key":"1169_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-024-07134-4","volume":"627","author":"S Nakandakari-Higa","year":"2024","unstructured":"Nakandakari-Higa, S. et al. Universal recording of immune cell interactions in vivo. Nature 627, 399\u2013406 (2024).","journal-title":"Nature"},{"key":"1169_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/cbic.201700517","volume":"19","author":"KD Nikghalb","year":"2018","unstructured":"Nikghalb, K. D. et al. Expanding the scope of sortase-mediated ligations by using sortase homologues. ChemBioChem 19, 185\u2013195 (2018).","journal-title":"ChemBioChem"},{"key":"1169_CR37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41565-023-01333-2","volume":"18","author":"Y Du","year":"2023","unstructured":"Du, Y. et al. Membrane-anchored DNA nanojunctions enable closer antigen-presenting cell-T-cell contact in elevated T-cell receptor triggering. Nat. Nanotechnol. 18, 818\u2013827 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"1169_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1126\/science.abj3013","volume":"375","author":"D Schraivogel","year":"2022","unstructured":"Schraivogel, D. et al. High-speed fluorescence image-enabled cell sorting. Science 375, 315\u2013320 (2022).","journal-title":"Science"},{"key":"1169_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg7995","volume":"9","author":"D Barras","year":"2024","unstructured":"Barras, D. et al. Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T\u2013myeloid cell networks in melanoma. Sci. Immunol. 9, eadg7995 (2024).","journal-title":"Sci. Immunol."},{"key":"1169_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s43018-022-00338-5","volume":"3","author":"M Cohen","year":"2022","unstructured":"Cohen, M. et al. The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response. Nat. Cancer 3, 303\u2013317 (2022).","journal-title":"Nat. Cancer"},{"key":"1169_CR41","doi-asserted-by":"publisher","first-page":"13119","DOI":"10.1073\/pnas.93.23.13119","volume":"93","author":"M Otsuji","year":"1996","unstructured":"Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y. & Saito, T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 \u03b6 chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl Acad. Sci. USA 93, 13119\u201313124 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1169_CR42","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1609","volume":"13","author":"S Nagaraj","year":"2007","unstructured":"Nagaraj, S. et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 13, 828\u2013835 (2007).","journal-title":"Nat. Med."},{"key":"1169_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar, V., Patel, S., Tcyganov, E. & Gabrilovich, D. I. The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol. 37, 208\u2013220 (2016).","journal-title":"Trends Immunol."},{"key":"1169_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253\u2013268 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1169_CR45","doi-asserted-by":"publisher","first-page":"e34317","DOI":"10.7554\/eLife.34317","volume":"7","author":"I Zimmermann","year":"2018","unstructured":"Zimmermann, I. et al. Synthetic single domain antibodies for the conformational trapping of membrane proteins. eLife 7, e34317 (2018).","journal-title":"eLife"},{"key":"1169_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","volume":"618","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. Tumour immune rejection triggered by activation of \u03b12-adrenergic receptors. Nature 618, 607\u2013615 (2023).","journal-title":"Nature"},{"key":"1169_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ccell.2023.12.005","volume":"42","author":"M Benguigui","year":"2024","unstructured":"Benguigui, M. et al. Interferon-stimulated neutrophils as a predictor of immunotherapy response. Cancer Cell 42, 253\u2013265 (2024).","journal-title":"Cancer Cell"},{"key":"1169_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207\u2013211 (2015).","journal-title":"Science"},{"key":"1169_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide, T. N. et al. Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy. Cancer Cell 35, 238\u2013255 (2019).","journal-title":"Cancer Cell"},{"key":"1169_CR50","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-16-3556","volume":"77","author":"A Prat","year":"2017","unstructured":"Prat, A. et al. Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma. Cancer Res. 77, 3540\u20133550 (2017).","journal-title":"Cancer Res."},{"key":"1169_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi, S., Yuan, R. & Engleman, E. G. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu. Rev. Pathol. 16, 223\u2013249 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"1169_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. & Hellmann, M. D. Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37, 443\u2013455 (2020).","journal-title":"Cancer Cell"},{"key":"1169_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41590-024-02029-y","volume":"26","author":"E Eruslanov","year":"2025","unstructured":"Eruslanov, E., Nefedova, Y. & Gabrilovich, D. I. The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting. Nat. Immunol. 26, 17\u201328 (2025).","journal-title":"Nat. Immunol."},{"key":"1169_CR54","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","volume":"172","author":"S Kusmartsev","year":"2004","unstructured":"Kusmartsev, S., Nefedova, Y., Yoder, D. & Gabrilovich, D. I. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172, 989\u2013999 (2004).","journal-title":"J. Immunol."},{"key":"1169_CR55","doi-asserted-by":"publisher","first-page":"eaaw9159","DOI":"10.1126\/sciimmunol.aaw9159","volume":"4","author":"Y Si","year":"2019","unstructured":"Si, Y. et al. Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue. Sci. Immunol. 4, eaaw9159 (2019).","journal-title":"Sci. Immunol."},{"key":"1169_CR56","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1182\/blood-2005-11-012328","volume":"108","author":"JI Elliott","year":"2006","unstructured":"Elliott, J. I. et al. Phosphatidylserine exposure in B lymphocytes: a role for lipid packing. Blood 108, 1611\u20131617 (2006).","journal-title":"Blood"},{"key":"1169_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13385-x","volume":"10","author":"JA Rudd-Schmidt","year":"2019","unstructured":"Rudd-Schmidt, J. A. et al. Lipid order and charge protect killer T cells from accidental death. Nat. Commun. 10, 5396 (2019).","journal-title":"Nat. Commun."},{"key":"1169_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","volume":"6","author":"Z Yan","year":"2025","unstructured":"Yan, Z., Wang, C., Wu, J., Wang, J. & Ma, T. TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives. Mol. Biomed. 6, 27 (2025).","journal-title":"Mol. Biomed."},{"key":"1169_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","volume":"13","author":"AT McNutt","year":"2021","unstructured":"McNutt, A. T. et al. GNINA 1.0: molecular docking with deep learning. J. Cheminformatics 13, 43 (2021).","journal-title":"J. Cheminformatics"},{"key":"1169_CR60","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4421","volume":"12","author":"H Susila","year":"2022","unstructured":"Susila, H. et al. In vitro assays to evaluate specificity and affinity in protein\u2013phospholipid interactions. Bio Protoc. 12, e4421 (2022).","journal-title":"Bio Protoc."},{"key":"1169_CR61","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"1169_CR62","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput. Chem."},{"key":"1169_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41615-w","volume":"14","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. Structural insights into the mechanism of GTP initiation of microtubule assembly. Nat. Commun. 14, 5980 (2023).","journal-title":"Nat. Commun."},{"key":"1169_CR64","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/jcc.25382","volume":"39","author":"DR Roe","year":"2018","unstructured":"Roe, D. R. & Cheatham, T. E. III. Parallelization of CPPTRAJ enables large scale analysis of molecular dynamics trajectory data. J. Comput. Chem. 39, 2110\u20132117 (2018).","journal-title":"J. Comput. Chem."},{"key":"1169_CR65","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller III","year":"2012","unstructured":"Miller, B. R. III et al. MMPBSA.py: an efficient program for end-state free energy calculations. J. Chem. Theory Comput. 8, 3314\u20133321 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"1169_CR66","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/s41596-020-0304-x","volume":"15","author":"I Zimmermann","year":"2020","unstructured":"Zimmermann, I. et al. Generation of synthetic nanobodies against delicate proteins. Nat. Protoc. 15, 1707\u20131741 (2020).","journal-title":"Nat. Protoc."},{"key":"1169_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23324-4","volume":"12","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).","journal-title":"Nat. Commun."},{"key":"1169_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"1169_CR69","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01169-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:01:45Z","timestamp":1784901705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01169-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":69,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1038\/s43018-026-01169-4","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}